[Federal Register Volume 60, Number 54 (Tuesday, March 21, 1995)]
[Notices]
[Page 14950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7068]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advisory Committee Meeting; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of meeting of the Arthritis Advisory Committee. 
This meeting was announced in the Federal Register of February 17, 1995 
(60 FR 9338). This amendment is being made to announce the cancellation 
of the open committee discussion portion of the meeting and adjustment 
of the starting time. There are no other changes. This amendment will 
be announced at the beginning of the open portion of the meeting.

FOR FURTHER INFORMATION CONTACT: Isaac F. Roubein, Center for Drug 
Evaluation and Research (HFD-9), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-443-5455, or FDA Advisory 
Committee Information Hotline, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), Arthritis Advisory Committee, code 12532.

SUPPLEMENTARY INFORMATION: In the Federal Register of February 17, 1995 
(60 FR 9338), FDA announced that the Arthritis Advisory Committee would 
hold a meeting on March 27, 1995.
    On page 9338, column 2, the ``Date, time, and place'' portion is 
amended to read as follows:
     Date, time, and place. March 27, 1995, 9 a.m., Holiday Inn--Silver 
Spring, Silver Room, 8777 Georgia Ave., Silver Spring, MD.
    On page 9338, column 2, the ``Type of meeting and contact person'' 
portion is amended to read as follows:
     Type of meeting and contact person. Open public hearing, 9 a.m. to 
10 a.m., unless public participation does not last that long; closed 
committee deliberations, 10 a.m. to 4 p.m.; Isaac F. Roubein, Center 
for Drug Evaluation and Research (HFD-9), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-443-5455, or FDA Advisory 
Committee Information Hotline, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), Arthritis Advisory Committee, code 12532.

    Dated: March 16, 1995.
Linda A. Suydam,
Interim Deputy Commissioner for Operations.
[FR Doc. 95-7068 Filed 3-17-95; 3:46 pm]
BILLING CODE 4160-01-F